Wells Fargo
NVOS

Wells Fargo’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Wells Fargo’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-121
Closed -$59 – 7749
2024
Q1 		$59 Buy
121
+8
+7% +$5 ﹤0.01% 6785
2023
Q4 		$93 Buy
113
+19
+20% +$39 ﹤0.01% 6791
2023
Q3 		$281 Buy
94
+6
+7% +$11 ﹤0.01% 6501
2023
Q2 		$131 Buy
88
+13
+17% +$18 ﹤0.01% 6814
2023
Q1 		$93 Buy
75
+66
+733% +$88 ﹤0.01% 6955
2022
Q4 		$17 Buy
9
+1
+13% +$3 ﹤0.01% 7322
2022
Q3 		$0 Buy
8
+1
+14% +$16 ﹤0.01% 7686
2022
Q2 		$0 Buy
7
+1
+17% +$20 ﹤0.01% 7790
2022
Q1 		$0 Buy
6
+1
+20% +$17 ﹤0.01% 8123
2021
Q4 		$0 Hold
5
– – ﹤0.01% 8059
2021
Q3 		$0 Hold
5
– – ﹤0.01% 7735
2021
Q2 		$0 Buy
+5
New +$125 ﹤0.01% 7668

Other funds holding NVOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo's NVOS Position: Q2 2024 in Review

Wells Fargo sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q2 2024, closing a stake of 121 shares — an estimated $59 sold.

Wells Fargo first reported a position in NVOS in Q2 2021 and held it in 12 quarters. The position peaked at $281 in Q3 2023. 16 funds tracked by Wall St. Rank hold NVOS as of Q2 2024.

  • Wells Fargo reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 121 Novo Integrated Sciences, Inc. Common Stock shares in Q2 2024, an estimated $59.
  • Wells Fargo first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Wells Fargo's Novo Integrated Sciences, Inc. Common Stock position peaked at $281 in Q3 2023.
  • 16 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.